{
    "Trade/Device Name(s)": [
        "Precinorm CK-MB",
        "Precipath CK-MB Controls"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K062972",
    "Predicate Device Reference 510(k) Number(s)": [
        "K003158"
    ],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "October 13, 2006",
    "Summary Letter Received Date": "September 29, 2006",
    "Submission Date": "September 28, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "CK",
        "CK-MB"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Roche/Hitachi Analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Quantitative methods for CK and CK-MB"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Roche Diagnostics Precinorm CK-MB and Precipath CK-MB controls as quality control materials for CK and CK-MB on Roche/Hitachi analyzers",
    "Indications for Use Summary": "Intended for quality control by monitoring accuracy and precision for quantitative methods specified in the value sheet to estimate test precision and detect analytical deviations in Roche test systems",
    "fda_folder": "Clinical Chemistry"
}